Shopping Cart
Rybelsus (semaglutide)
Rybelsus (semaglutide)
Rybelsus (semaglutide)
Rybelsus (semaglutide)
Rybelsus (semaglutide)
Rybelsus (semaglutide)
Rybelsus (semaglutide)
Rybelsus (semaglutide)
Rybelsus (semaglutide)
Rybelsus (semaglutide)
Rybelsus (semaglutide)
Rybelsus (semaglutide)
Rybelsus (semaglutide)
Rybelsus (semaglutide)
Rybelsus (semaglutide)

Rybelsus (semaglutide)

$148.88 SGD $200.00 SGD Save $51.12 SGD
Dose
Quantity
Only 1994 left
Volume Pricing
Quantity
Price
1+
$148.88 SGD each

What is Rybelsus?

Rybelsus is a brand-name prescription medication that’s FDA-approved to treat type 2 diabetes. The drug helps control blood sugar in adults when used with diet and exercise. Type 2 diabetes is a condition in which your blood sugar level becomes too high due to problems with a hormone called insulin.

If diet and exercise aren’t helping you manage your type 2 diabetes, Rybelsus shouldn’t be the first medication that you try. Rybelsus isn’t approved to treat type 1 diabetes or a complication of diabetes called diabetic ketoacidosis.

Also, Rybelsus hasn’t been studied in people who have had a pancreas problem known as pancreatitis. So if you have had this condition, your doctor may recommend a different diabetes medication.

Rybelsus contains one active ingredient: semaglutide. Rybelsus belongs to a group of medications called glucagon-like peptide-1 (GLP-1) receptor agonists.

Rybelsus comes as a tablet that you swallow. It’s available in three strengths: 3 mg, 7 mg, and 14 mg. You’ll take Rybelsus once a day.

FDA approval

The Food and Drug Administration (FDA) approved Rybelsus in 2017.

Effectiveness

study has shown that Rybelsus helps lower blood sugar more than a placebo (treatment with no active drug). Researchers used blood tests to measure the level of hemoglobin A1c (HbA1c), which is a marker of blood sugar control. Target values of 7% are common for HbA1c, but this varies from person to person. Talk with your doctor about the target goal for your treatment.

In a 26-week study of adults with type 2 diabetes, those who took Rybelsus had a decrease in their HbA1c level of 1.2% to 1.4%. This was compared with a decrease of only 0.3% in people who took a placebo. At the end of the study, about 69% to 77% of people who took Rybelsus had an HbA1c level of less than 7%, compared with 31% of those who took a placebo.

Rybelsus generic

Rybelsus is available only as a brand-name medication. It’s not currently available in generic form. A generic drug is an exact copy of the active drug in a brand-name medication.

Rybelsus contains one active drug: semaglutide. (As the active drug, semaglutide is the ingredient that makes Rybelsus work.) Semaglutide is also the active drug in a brand-name medication called Ozempic.